Abstract:Magnetic resonance imaging(MRI) has been extensively used in clinical diagnosis and currently over 30% MRI runs are performed in the presence of contrast agents. However, commercially available contrast agents originated from small molecules typically exhibit relatively low relaxivities and insufficient circulation time. Therefore, there is a long pursuit to develop new contrast agents with high relaxivities to discriminate pathological tissues from normal ones. Compared with small molecule MRI contrast agents, the incorporation of small molecule contrast agents into macromolecular scaffolds allows for constructing macromolecular MRI contrast agents, remarkably elevating the relaxivities due in part to increased rotational correlation time(τR). Moreover, if the macromolecular scaffolds are responsive to external stimuli, the MRI signals could be selectively switched on at the desired sites(e.g., pathological tissues), further intensifying the imaging contrast. In this feature article, we outline the recent achievements in the fabrication of stimuli-responsive macromolecular MRI contrast agents. Specifically, macromolecular contrast agents being responsive to acidic p H, redox potentials, and other stimuli including photoirradiation, pathogens, and salt concentration are discussed. These smart contrast agents could affect either longitudinal(T1) or transverse(T2) relaxation times of water protons or other nuclei(e.g.,19 F), exhibiting enhanced signals in pathological tissues yet suppressed signals in normal ones and displaying promising potentials in in vitro and in vivo MRI applications.

Aptamer-Targeted Magnetic Resonance Imaging Contrast Agents and Their Applications

Research Progress of Magnetic Resonance Imaging Contrast Agents

Gadolinium‐based Contrast Agents for Magnetic Resonance Cancer Imaging

Advances in magnetic nanoparticle-based magnetic resonance imaging contrast agents

Gadolinium(III)-based Polymeric Magnetic Resonance Imaging Agents for Tumor Imaging

Gadolinium-based Nanoscale MRI Contrast Agents for Tumor Imaging

Macromolecular MRI Contrast Agents: Structures, Properties and Applications

Key Insights on the Classification and Theranostic Applications of Magnetic Resonance Imaging Contrast Agents

A dual-targeted Gd-based contrast agent for magnetic resonance imaging in tumor diagnosis

Progress in research of nanomedicine-based gadolinium contrast agents for magnetic resonance imaging

Engineering of Inorganic Nanoparticles As Magnetic Resonance Imaging Contrast Agents.

Biodegradable Nanoglobular Magnetic Resonance Imaging Contrast Agent Constructed with Host-Guest Self-Assembly for Tumor-Targeted Imaging.

Advances in nanotechnology-based targeted-contrast agents for computed tomography and magnetic resonance

Research progress in bio-responsive MRI contrast agent

Recent Advances on Stimuli-Responsive Macromolecular Magnetic Resonance Imaging (MRI) Contrast Agents

Geometrical Confinement of Gadolinium Oxide Nanoparticles in Poly(ethylene Glycol)/arginylglycylaspartic Acid-Modified Mesoporous Carbon Nanospheres As an Enhanced T1 Magnetic Resonance Imaging Contrast Agent.

The Development of Dendritic Gd-Dtpa Complexes for Mri Contrast Agents

A Targeted Nanoglobular Contrast Agent from Host-Guest Self-Assembly for MR Cancer Molecular Imaging.

Protein MRI Contrast Agents as an Effective Approach for Precision Molecular Imaging

Lanthanide Nanoparticles: Promising Candidates For Magnetic Resonance Imaging Contrast Enhancement